Mohamed-Saiel Saeed Alhamdani
Overview
Explore the profile of Mohamed-Saiel Saeed Alhamdani including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
117
Followers
0
Related Specialties
Related Specialties
Co-Authors
Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Alhamdani M, Al-Kassir A, Abbas F, Jaleel N, Al-Taee M
Nephron Clin Pract
. 2007 Aug;
107(1):c26-34.
PMID: 17664891
Background/aim: Toxicity with advanced glycation end products (AGEs) is a major problem in uremic patients. Treatment with peritoneal dialysis (PD) exacerbates AGE formation as a result of bioincompatibility of the...
2.
Alhamdani M, Al-Azzawie H, Abbas F
Perit Dial Int
. 2006 Dec;
27(1):86-9.
PMID: 17179517
Background: Formation of advanced glycation end-products (AGEs) is a major problem in uremic patients treated with peritoneal dialysis (PD). Application of additives with known anti-glycosylation properties to PD fluid may...
3.
Alhamdani M, Al-Kassir A, Jaleel N, Hmood A, Ali H
Am J Nephrol
. 2006 Jun;
26(3):299-303.
PMID: 16804293
Background/aims: Several studies have implicated reactive carbonyl compounds (RCOs), especially those derived from lipid peroxidation, in the development of complications frequently associated with hemodialysis (HD) treatment. However, there is still...
4.
Al-Azzawie H, Alhamdani M
Life Sci
. 2005 Oct;
78(12):1371-7.
PMID: 16236331
Patients with diabetes mellitus are likely to develop certain complication such as retinopathy, nephropathy and neuropathy as a result of oxidative stress and overwhelming free radicals. Treatment of diabetic patients...